04/12/2024
4:59 PM | Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
4:10 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
3:58 PM | Sutro Biopharma (Filer)
| Form 424B5 | |
04/02/2024
5:04 AM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:30 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
3:28 PM | NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
| Form 4/A | |
03/07/2024
6:12 PM | FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/07/2024
3:26 PM | Chung Jane (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:28 PM | Gerber Hans-Peter (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:31 PM | NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:32 PM | Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:18 PM | ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:21 PM | Chung Jane (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:40 PM | NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:29 PM | ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:15 PM | Borgman Anne Elizabeth (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
3:33 PM | Sutro Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/13/2024
11:16 AM | Sutro Biopharma (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/12/2024
5:06 AM | Rubric Capital Management LP (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G/A | |
02/09/2024
3:27 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
6:56 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G/A | |
01/31/2024
3:23 PM | Sutro Biopharma (Issuer)
Vasquez Nicki (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:25 PM | FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:28 PM | ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:29 PM | NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:54 PM | INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G | |
01/08/2024
6:31 AM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
3:19 PM | Chung Jane (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
11:15 PM | Sutro Biopharma (Filer)
| Form EFFECT | |
11/21/2023
3:05 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
4:18 PM | Sutro Biopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/13/2023
3:30 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
3:32 PM | Sutro Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2023
3:52 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Sutro Biopharma (Subject)
| Form SC 13G | |
10/04/2023
3:31 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2023
3:19 PM | Gerber Hans-Peter (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
3:15 PM | Gerber Hans-Peter (Reporting)
Sutro Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/29/2023
3:40 PM | Shtylla Brunilda (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2023
3:18 PM | Shtylla Brunilda (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
3:46 PM | Shtylla Brunilda (Reporting)
Sutro Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/13/2023
5:40 PM | Sutro Biopharma (Issuer)
Vasquez Nicki (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
06/29/2023
5:28 PM | Petree Daniel H (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
7:01 AM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
3:31 PM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2023
5:51 PM | Hunter Heidi (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
5:30 PM | Dybbs Michael (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
5:32 PM | Freund John Gordon (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
5:37 PM | Lobacki Joseph M (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
5:38 PM | MATSUI CONNIE (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
5:38 PM | PANEK JAMES P (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
5:39 PM | Petree Daniel H (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
5:40 PM | Sutro Biopharma (Issuer)
Wigginton Jon Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
7:01 AM | Sutro Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
7:05 AM | Sutro Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2023
5:51 PM | Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
5:26 PM | Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/28/2023
3:10 PM | Sutro Biopharma (Filer)
| Form ARS | |
